← FDA Drug Approvals (Drugs@FDA)
ELETRIPTAN HYDROBROMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2022-07-13
Drug application
- FDA Application #
ANDA215467- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ELETRIPTAN HYDROBROMIDE
- Generic name
- Eletriptan Hydrobromide
- Active ingredients
- ELETRIPTAN HYDROBROMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- First approval
- 2022-07-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown